Compare ProShares Ultra Bitcoin ETF (BITU) vs Moderna, Inc. (MRNA) Price & Performance

ProShares Ultra Bitcoin ETFTrade

Moderna, Inc.Trade

Price performance (Past 24H)

Key statistics

ProShares Ultra Bitcoin ETF vs Moderna, Inc. — how do they compare? ProShares Ultra Bitcoin ETF trades at $9.26, while Moderna, Inc. trades at $60.78 (market cap $23.88B). The key difference: Moderna, Inc. is trading nearer its 52-week high, ProShares Ultra Bitcoin ETF nearer its low. Which is the better fit depends on your goals.

	BITU	MRNA
Sector	Leveraged / Inverse	Health
52-Week High	$64.41	$81.80
52-Week Low	$8.12	$22.36
Market Cap	—	$23.88B
Enterprise Value	—	$20.03B

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

ProShares Ultra Bitcoin ETF

BITU trades at $9.64, up 1.69% with neutral technical signals. The stock shows mixed momentum with bullish moving averages but neutral oscillators. Recent dividend payments of $0.01-$0.02 provide shareholder returns, though key financial ratios remain undisclosed in current filings.

The outlook remains cautious with technical indicators showing limited directional bias. Investment opportunity exists through dividend yield, but risks include volatility and lack of clear fundamental data. Analyst sentiment appears neutral with equal buy/sell recommendations.

Moderna, Inc.

No Aura AI signal available yet.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BITU

View details →

MRNA

New report analyzes 1,350+ precision medicine deals from 2019-2026, revealing market trends and deal structures.Researchandmarkets.Com · 4 days agoNeutral Global influenza vaccine market to grow to $13.32B by 2030, driven by aging population and vaccine innovationsResearchandmarkets.Com · 4 days agoNeutral View details →

About ProShares Ultra Bitcoin ETF

BITU is a leveraged ETF that seeks to provide two times (2x) the daily performance of Bitcoin. It is designed for sophisticated investors looking for magnified exposure to Bitcoin’s daily price movements.

About Moderna, Inc.

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.